Iprocrolol

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 13:21, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Iprocrolol
Clinical data
ATC code
  • None
Identifiers
  • 4-Hydroxy-9-[2-hydroxy-3-(isopropylamino)propoxy]-7-methyl-2,3-dihydropyrano[3,2-f]benzofuran-5-one
CAS Number
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC18H23NO6
Molar mass349.383 g·mol−1
3D model (JSmol)
  • CC(C)NCC(O)COc2c1OC(\C)=C/C(=O)c1c(O)c3CCOc23
  • InChI=1S/C18H23NO6/c1-9(2)19-7-11(20)8-24-18-16-12(4-5-23-16)15(22)14-13(21)6-10(3)25-17(14)18/h6,9,11,19-20,22H,4-5,7-8H2,1-3H3
  • Key:YSMZUAMUQKMUAL-UHFFFAOYSA-N

Iprocrolol is a beta blocker that was never marketed.[1]

References

  1. ^ Ganellin, C.R.; Triggle, David J. (November 21, 1996). Dictionary of Pharmacological Agents. Vol. 3. CRC Press. p. 1156. ISBN 0412466309.
Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Iprocrolol&oldid=963903990"